Related Experiment Videos
Complement receptors (C3b, C4b/C3d) unbalance on CLL lymphocytes
Insights
Chronic Lymphatic Leukemia (CLL) patients show increased C3d complement receptor (CRL) levels on lymphocytes. Treatment appears to reduce all CRL types non-selectively in CLL patients.
Area of Science:
- Immunology
- Hematology
- Complement System
Background:
- Lymphocytes play a crucial role in immune responses.
- Complement receptors (CRLs) on lymphocytes are involved in immune regulation.
- Chronic Lymphatic Leukemia (CLL) is a hematological malignancy characterized by abnormal lymphocyte proliferation.
Purpose of the Study:
- To investigate complement receptor (CRL) expression on lymphocytes in healthy donors and CLL patients.
- To analyze the effect of treatment on CRL expression in CLL.
- To hypothesize the immunophenotype of proliferating lymphocytes in CLL.
Main Methods:
- Analysis of lymphocytes from human peripheral blood using immunoadherence assays.
- Quantification of lymphocytes bearing C3b, C4b, and C3d complement receptors (CRLs).
- Comparison of CRL expression between healthy controls, CLL patients, and CLL patients undergoing treatment.
Main Results:
- A significant increase in C3dCRL-bearing lymphocytes was observed in CLL patients compared to controls.
- Lymphocytes with immunoadherence receptors were also slightly augmented in CLL patients.
- CRL populations in CLL patients under treatment mirrored the profile of untreated CLL, suggesting non-selective reduction.
Conclusions:
- CLL lymphocytes exhibit altered complement receptor expression, particularly an elevation of C3dCRL.
- Current treatments may not selectively target specific CRL types on lymphocytes in CLL.
- The proliferating lymphocyte population in CLL is hypothesized to be predominantly sIg+, C3d+/C3b-, C4b-, with a subset also being C3d+/C3b+, C4b+.
Abstract:
A study of lymphocytes bearing C3b, C4b and C3d complement receptor (CRL) was performed on human peripheral blood from 16 healthy donors and 12 patients affected with Chronic Lymphatic Leukemia (CLL). In the latter group a clear rise of C3dCRL was demonstrated, when compared with immunoadherence receptors bearing lymphocytes. However, when compared with controls, also these latter were slightly augmented. Furthermore in CLL under treatment CRL populations showed the same profile as CLL: so it was suggested that the treatment reduced not selectively all the three types of CRL, within the population of sIg bearing lymphocytes. Here we discuss the hypothesis that, in CLL, the proliferating lymphocytes population is chiefly sIg+, C3d+/C3b-, C4b-, but also sIg+, C3d+/C3b+, C4b+.